Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 25.13 Billion INR | -15.61% |
| 2022 | 29.77 Billion INR | 19.12% |
| 2021 | 24.99 Billion INR | 9.79% |
| 2020 | 22.76 Billion INR | 6.61% |
| 2019 | 21.35 Billion INR | -5.17% |
| 2018 | 22.52 Billion INR | 10.91% |
| 2017 | 20.3 Billion INR | -5.07% |
| 2016 | 21.39 Billion INR | 36.44% |
| 2015 | 15.67 Billion INR | 23.54% |
| 2014 | 12.69 Billion INR | 36.03% |
| 2013 | 9.32 Billion INR | 10.59% |
| 2012 | 8.43 Billion INR | 7.09% |
| 2011 | 7.87 Billion INR | -2.4% |
| 2010 | 8.07 Billion INR | 13.91% |
| 2009 | 7.08 Billion INR | 12.41% |
| 2008 | 6.3 Billion INR | 57.27% |
| 2007 | 4 Billion INR | 48.58% |
| 2006 | 2.69 Billion INR | 71.21% |
| 2005 | 1.57 Billion INR | 31.91% |
| 2004 | 1.19 Billion INR | 45.35% |
| 2003 | 821.6 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 25.13 Billion INR | -15.61% |
| 2023 Q2 | 26.49 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 25.13 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 28.64 Billion INR | 0.0% |
| 2022 Q4 | 29.77 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 29.77 Billion INR | 19.12% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 24.99 Billion INR | 0.0% |
| 2021 Q2 | 25.3 Billion INR | 0.0% |
| 2021 FY | 24.99 Billion INR | 9.79% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 22.76 Billion INR | 6.61% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 22.02 Billion INR | 0.0% |
| 2020 Q4 | 22.76 Billion INR | 0.0% |
| 2019 FY | 21.35 Billion INR | -5.17% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 21.35 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 21.78 Billion INR | 0.0% |
| 2018 FY | 22.52 Billion INR | 10.91% |
| 2018 Q4 | 22.52 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 20.57 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 20.3 Billion INR | -5.07% |
| 2017 Q4 | 20.3 Billion INR | 0.0% |
| 2017 Q2 | 21.59 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 21.39 Billion INR | 36.44% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 19.02 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 21.39 Billion INR | 0.0% |
| 2015 FY | 15.67 Billion INR | 23.54% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 15.67 Billion INR | 0.0% |
| 2015 Q2 | 15.39 Billion INR | 0.0% |
| 2014 Q2 | 10.57 Billion INR | 0.0% |
| 2014 Q4 | 12.69 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 12.69 Billion INR | 36.03% |
| 2013 FY | 9.32 Billion INR | 10.59% |
| 2013 Q4 | 9.32 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 9.38 Billion INR | 0.0% |
| 2012 FY | 8.43 Billion INR | 7.09% |
| 2012 Q4 | 8.43 Billion INR | 0.0% |
| 2012 Q2 | 8.32 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2011 Q4 | 7.87 Billion INR | 0.0% |
| 2011 FY | 7.87 Billion INR | -2.4% |
| 2010 FY | 8.07 Billion INR | 13.91% |
| 2009 FY | 7.08 Billion INR | 12.41% |
| 2008 FY | 6.3 Billion INR | 57.27% |
| 2007 FY | 4 Billion INR | 48.58% |
| 2006 FY | 2.69 Billion INR | 71.21% |
| 2005 FY | 1.57 Billion INR | 31.91% |
| 2004 FY | 1.19 Billion INR | 45.35% |
| 2003 FY | 821.6 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sigachi Industries Limited | 707.2 Million INR | -3453.487% |
| Ind-Swift Limited | 640.91 Million INR | -3821.036% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -1644.711% |
| Sakar Healthcare Limited | 277.32 Million INR | -8961.82% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 74.378% |
| Innova Captab Limited | 1.44 Billion INR | -1644.98% |
| Divi's Laboratories Limited | 31.84 Billion INR | 21.073% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -1002.786% |
| Morepen Laboratories Limited | 2.48 Billion INR | -910.905% |
| Mankind Pharma Limited | 15.53 Billion INR | -61.771% |
| Sequent Scientific Limited | 3.46 Billion INR | -625.829% |
| Wanbury Limited | 360.23 Million INR | -6876.201% |
| Laurus Labs Limited | 18.45 Billion INR | -36.178% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -254.374% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -277.0% |
| Alembic Limited | 113.4 Million INR | -22060.944% |
| Hikal Limited | 3.03 Billion INR | -727.424% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -52.905% |
| Neuland Laboratories Limited | 3.5 Billion INR | -617.15% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -400.1% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -491.529% |
| Themis Medicare Limited | 705.74 Million INR | -3460.859% |
| RPG Life Sciences Limited | 1.01 Billion INR | -2388.169% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 26.987% |
| Lupin Limited | 49.53 Billion INR | 49.271% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -8594.264% |
| Wockhardt Limited | 6.4 Billion INR | -292.664% |
| Vaishali Pharma Limited | 3.79 Million INR | -661751.725% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -290.917% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -16657.025% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -94.871% |
| FDC Limited | 3.88 Billion INR | -546.214% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 60.457% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -62915.321% |
| Eris Lifesciences Limited | 1.89 Billion INR | -1229.432% |
| Venus Remedies Limited | 1.21 Billion INR | -1965.125% |
| ZIM Laboratories Limited | 812.62 Million INR | -2992.495% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -2021.662% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -60064.017% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | -592.224% |
| Shilpa Medicare Limited | 3.44 Billion INR | -628.572% |
| Albert David Limited | 436.12 Million INR | -5662.279% |
| Ajanta Pharma Limited | 8.28 Billion INR | -203.377% |
| Hester Biosciences Limited | 755.81 Million INR | -3224.977% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -986.98% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -598.652% |
| Gufic Biosciences Limited | 2 Billion INR | -1153.504% |
| Windlas Biotech Limited | 621.89 Million INR | -3940.99% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -2203.227% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -7147.29% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -1932.558% |
| Granules India Limited | 13 Billion INR | -93.231% |
| Aarti Drugs Limited | 4.85 Billion INR | -417.206% |
| Bal Pharma Limited | 878.11 Million INR | -2761.873% |
| Alkem Laboratories Limited | 26.61 Billion INR | 5.566% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 74.534% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -3156.593% |
| Medicamen Biotech Limited | 593.75 Million INR | -4132.493% |
| Unichem Laboratories Limited | 7.04 Billion INR | -256.625% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -8378.065% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -98462.615% |
| Valiant Laboratories Limited | 100.15 Million INR | -24991.869% |
| Orchid Pharma Limited | 2.64 Billion INR | -851.099% |
| Medico Remedies Limited | 163.37 Million INR | -15282.385% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -23930.628% |
| Ipca Laboratories Limited | 24.71 Billion INR | -1.689% |
| Brooks Laboratories Limited | 96.1 Million INR | -26048.198% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -11820.646% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -10.27% |
| NATCO Pharma Limited | 7 Billion INR | -258.751% |
| Suven Life Sciences Limited | 7.08 Million INR | -354600.212% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -25552.801% |
| Strides Pharma Science Limited | 11.26 Billion INR | -123.136% |
| Indoco Remedies Limited | 3.53 Billion INR | -611.791% |
| Alpa Laboratories Limited | 136.65 Million INR | -18290.017% |
| Lasa Supergenerics Limited | 190.43 Million INR | -13096.441% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -169792.577% |